retatrutide clinical trials results Helped Adults With Obesity Lose Up to 30 Percent of Their Body Weight in New Trial retatrutide human trials retatrutide dosing

Other common side effects include headaches, injection site reactions, and nasopharyngitis, but these do not usually result in discontinuation of the drug [74-77]

10.1007/s12325-022-02153-x 42 KangX.WangD.ZhangL.HuangT.LiuS.FengX.et al (2023)

Everything that comes fast, goes fast, she says, noting that she started seeing a nutritionist and working out, and has since been able to start losing the weight again

GLP-1 drugs are expensive enough to be out of reach for most people, unless they're covered by insurance

New England Journal of Medicine 389 (10)

Today, retatrutide, the GIP/GLP-1/glucagon triple agonist, just delivered TRIUMPH-2 top-line results